Featured Issue Briefs
The Battle on the Home Front: Jonathan Gadsden's Story
Marine Lance Corporal's story reflects the growing need for new antibiotics that can treat dangerous diseases, against which most drugs are useless. Read More
Facilitating Medical Device Innovation: De Novo Reform
The de novo process -- which requests lower-risk reclassification of medical devices and entry into the marketplace -- as it exists now is not achieving its purpose and has instead added unnecessary and time-consuming requirements. Read More
Food Products Recalled by FDA
Since President Obama signed the FDA Food Safety Modernization Act into law, at least 149 FDA-regulated food products have been recalled due to potential pathogenic contamination. Read More
More Issue Briefs
| Date | Issue Briefs | Topic |
|---|---|---|
| Jul 21, 2009 |
Pew letter to the FDA in response to their public recognition of animal agriculture's contribution to antimicrobial resistanceThe Pew Campaign on Human Health and Industrial Farming (Pew) would like to extend our sincere thanks to you both for taking the time to meet with us on June 23 to discuss the contribution of animal agriculture to the growing public health crisis of antimicrobial resistance. We are deeply appreciative not only of your consideration of our viewpoints, but also the expertise and dedication that you bring to the U.S. Food and Drug Administration (FDA). More info |
Antibiotics in Food Animal Production |
| Jul 15, 2009 |
Testimony: Robert P. Martin Before the U.S. House of Representatives Committee on RulesTestimony from Robert P. Martin, Senior Officer, Pew Environment Group, before the U.S. House of Representatives Committee on Rules regarding the Preservation of Antibiotics for Medical Treatment Act (PAMTA). More info |
Antibiotics in Food Animal Production |
| Jul 10, 2009 |
Bill Comparison - Regulation of Overseas Drug ManufacturingThis issue brief from the Pew Prescription Project outlines the differences between bills from the U.S. House of Representatives and the U.S. Senate regarding regulation of overseas drug manufacturing. More info |
Drug Safety |
| Jul 2, 2009 |
Bill Summary - Counterfeit Drug Enforcement Act of 2009This issue brief is a summary of H.R. 2726 - The Counterfeit Drug Enforcement Act of 2009, also known as the Tim Fagan Law. More info |
Drug Safety, Medical Safety Policy |
| Jun 25, 2009 |
Regulatory Comment on Credit CARD Act Reasonable and Proportional RuleThe Pew Safe Credit Cards Project submitted comments to the Federal Reserve Board in regard to rulemaking under the Credit CARD Act of 2009. These comments focused specifically on the law’s requirement that penalty fees and charges must be reasonable and proportional to related cardholder omissions or violations. More info |
Credit Cards |
| Jun 10, 2009 |
FDA Globalization Act of 2009: Drug Safety ProvisionsThe Food and Drug Administration Globalization Act of 2009 (H.R.759) seeks to secure the safety of imported prescription drugs and active pharmaceutical ingredients through greater FDA authority and manufacturer responsibility, and increased inspections of prescription drug and active pharmaceutical ingredient manufacturing sites abroad. More info |
Drug Manufacturing and Distribution, Drug Safety |
| May 20, 2009 |
Curing Credit Card PenaltiesCongress is set to enact new legislation that will make credit cards safer and more fair for consumers. As lawmakers negotiate final details before President Obama can sign the bill, new analysis from the Pew Health Group highlights the importance of a safeguard found only in the Senate’s version of the law. More info |
Credit Cards |
| May 1, 2009 |
Testimony of Allan Coukell, Director of the Pew Prescription Project, on Protecting Consumers from Adulterated DrugsProtecting consumers against the risk of adulterated products is, of course, the original mission of the FDA. Today, the vast majority of pharmaceutical products sold in the United States today are not adulterated, but an increasingly complex supply chain creates new challenges and new risks – as recent events demonstrate. More info |
Drug Manufacturing and Distribution, Drug Safety |
| Apr 30, 2009 |
No Economic Advantage to Industrialized Pork ProductionIn October 2008, a panel formed to conduct a comprehensive, fact-based examination of key aspects of the farm animal industry. The report found that the current industrial method of raising pigs for food carries no economic advantage over more natural pig farming. The researchers determined that when the costs to society and communities are taken into account – particularly the costs of waste treatment - industrial animal production actually carries a higher price tag. More info |
Antibiotics in Food Animal Production |
| Mar 17, 2009 |
Teleconference on Legislation to Help Curtail Overuse of Antibiotics on Factory FarmsChipotle restaurant CEO joins Rep. Louise Slaughter (D-NY) and leading antibiotic expert to discuss the Preservation of Antibiotics for Medical Treatment Act of 2009. More info |
Antibiotics in Food Animal Production |
